Rise Nano Optics to Sponsor INVISION MATCH! 2026, Connecting SpectraGuard with Leading Independent Eye Care Practices

Company to participate in curated one-on-one meetings with leading independent optometry practice owners as it expands U.S. commercialization of SpectraGuard(TM)

Vancouver, British Columbia–(Newsfile Corp. – September 24, 2026) – Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) (“Rise” or the “Company“), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced that it will participate as a sponsor of INVISION MATCH! 2026, an invite-only industry event designed to connect leading independent optometry practice owners with innovative optical industry suppliers through curated, one-on-one business meetings.

The inaugural INVISION MATCH! will take place September 30 through October 2, 2026, at The Palms Hotel & Casino in Las Vegas, Nevada. Unlike a traditional trade show, MATCH! is structured around pre-scheduled individual meetings, hosted networking events and intentionally limited participation designed to facilitate substantive business discussions between suppliers and independent eye care practice owners.

Rise’s participation will provide the Company with direct access to a select group of independent optometry practice owners and an opportunity to introduce SpectraGuard as the Company continues to build commercial awareness and demand in the U.S. eye care market.

The Company’s proprietary SpectraGuard technology is a patented nanoparticle optical lens treatment designed to provide eye protection by filtering 100% of ultraviolet (UV) light and up to 90% of wavelengths between 400-600 nm, including blue light, while preserving natural visual clarity and color perception.

INVISION MATCH! is expected to bring together more than 20 private-practice optometry owners generating more than $1 million in annual revenue alongside a selected group of optical industry suppliers. Participating sponsors receive scheduled one-on-one meetings with verified decisionmakers actively evaluating products, technologies and services for their practices.

Erik Ritchie, Chief Commercial Officer of Rise Nano Optics, commented, “INVISION MATCH! gives us an opportunity to engage directly with a highly targeted group of independent eye care leaders and introduce them to the technology behind SpectraGuard. As we expand our network of laboratory partners, building awareness and demand among the eye care professionals those laboratories serve is an important part of our commercialization strategy. We believe the focused, one-on-one format of MATCH! provides an excellent environment to develop those relationships.”

Rise’s participation in INVISION MATCH! complements the Company’s lab-first commercialization strategy. Rise is developing a network of authorized optical laboratory partners capable of producing SpectraGuard lenses while selectively engaging eye care professionals to build awareness, generate demand and support adoption through those laboratory partners.

By combining laboratory partnerships with targeted engagement of eye care professionals, Rise is working to establish a scalable commercial ecosystem through which SpectraGuard can reach independent optical practices and their patients.

INVISION previously announced Rise as a sponsor alongside companies representing a range of optical products, technologies and business services. The event’s supplier participation is intentionally limited by category to create a focused environment for interaction between participating companies and practice owners.

About INVISION MATCH!

INVISION MATCH! is an invite-only event produced by INVISION and SmartWork Media designed to connect leading private-practice optometry owners with selected industry suppliers through curated, one-on-one business meetings. The event combines pre-scheduled meetings with hosted networking breakfasts, receptions, dinners and other relationship-building opportunities.

INVISION MATCH! 2026 will take place September 30-October 2, 2026, at The Palms Hotel & Casino in Las Vegas, Nevada.

For more information, visit: https://invisionmag.com/match/

About Rise
Rise Nano Optics Ltd. trades on the CSE under the ticker symbol “EYE”, on the OTCQB under the ticker symbol “RNOLF”, and on the Frankfurt Stock Exchange under the ticker symbol “U9Y”. Rise is a health technology company specializing in advanced nanotechnology lens solutions designed to selectively filter high-energy visible light wavelengths. Its patented SpectraGuard™ technology integrates nanomaterial innovation, ophthalmic research and scalable optical engineering to serve both clinical and consumer eyewear markets globally.

For more information, visit: www.risenanooptics.com

Forward‐Looking Statements

This news release contains forward-looking statements relating to the Company and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the future plans and objectives of the Company, are forward looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations are risks detailed from time to time in the filings made by the Company with securities regulations.

Readers are cautioned that forward-looking information is not based on historical facts but instead reflect the Company’s management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the demand for the Company’s products and technology, including SPECTRAGUARD™, the expansion of the Company’s business partnerships and the success of the Company’s patents and intellectual property, whether future or current. This forward-looking information may be affected by risks and uncertainties in the business of the Company and market conditions.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/315789